报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 93.35% | -0.25% | -0.01% | 5/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
2024-06-30 | 93.36% | 0.46% | 0.31% | 5/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
2024-03-31 | 93.07% | 2.28% | -0.28% | 4/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
2023-12-31 | 93.33% | 4.97% | -0.27% | 5/54 | 68.3% | 我武生物 | 95.26% | 行业排名> |
2023-09-30 | 93.59% | 4.76% | 0.7% | 3/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
2023-06-30 | 92.94% | 3.81% | 2.13% | 6/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
2023-03-31 | 91% | 1.8% | 2.35% | 7/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
2022-12-31 | 88.92% | -0.04% | -0.46% | 7/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
2022-09-30 | 89.33% | -1.13% | -0.22% | 8/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
2022-06-30 | 89.53% | -0.7% | 0.15% | 7/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
2022-03-31 | 89.39% | -0.2% | 0.5% | 12/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
2021-12-31 | 88.95% | -0.58% | -1.55% | 12/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
2021-09-30 | 90.35% | 2.13% | 0.22% | 8/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
2021-06-30 | 90.15% | 2.19% | 0.65% | 8/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
2021-03-31 | 89.57% | 2.12% | 0.12% | 11/54 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
2020-12-31 | 89.46% | 0.48% | 1.13% | 11/54 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
2020-09-30 | 88.47% | -0.11% | 0.28% | 10/54 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
2020-06-30 | 88.22% | 0.72% | 0.57% | 13/54 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
2020-03-31 | 87.72% | 2% | -1.49% | 10/54 | 70.26% | 我武生物 | 95.6% | 行业排名> |
2019-12-31 | 89.04% | 1.73% | 0.54% | 10/54 | 72.44% | 我武生物 | 96.43% | 行业排名> |
2019-09-30 | 88.57% | 2% | 1.11% | 6/54 | 70.09% | 我武生物 | 96.51% | 行业排名> |
2019-06-30 | 87.59% | 2% | 0.08% | 7/54 | 69.35% | 我武生物 | 96.46% | 行业排名> |
2018-12-31 | 87.52% | 0.48% | 0.48% | 10/54 | 71.54% | 我武生物 | 96.44% | 行业排名> |
2017-12-31 | 87.1% | -2.17% | -2.17% | 9/54 | -887.82% | 康辰药业 | 95.1% | 行业排名> |
2016-12-31 | 89.03% | 2% | 2% | 7/54 | 68.41% | 康辰药业 | 94.98% | 行业排名> |